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Abstract
Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology. Their
unique size-dependent properties make these materials superior and indispensable in many areas
of human activity. This brief review tries to summarise the most recent developments in the field
of applied nanomaterials, in particular their application in biology and medicine, and discusses their
commercialisation prospects.
Introduction
Nanotechnology [1] is enabling technology that deals
with nano-meter sized objects. It is expected that nanote-
chnology will be developed at several levels: materials,
devices and systems. The nanomaterials level is the most
advanced at present, both in scientific knowledge and in
commercial applications. A decade ago, nanoparticles
were studied because of their size-dependent physical and
chemical properties [2]. Now they have entered a com-
mercial exploration period [3,4].
Living organisms are built of cells that are typically 10 µm
across. However, the cell parts are much smaller and are
in the sub-micron size domain. Even smaller are the pro-
teins with a typical size of just 5 nm, which is comparable
with the dimensions of smallest manmade nanoparticles.
This simple size comparison gives an idea of using nano-
particles as very small probes that would allow us to spy
at the cellular machinery without introducing too much
interference [5]. Understanding of biological processes on
the nanoscale level is a strong driving force behind devel-
opment of nanotechnology [6].
Out of plethora of size-dependant physical properties
available to someone who is interested in the practical
side of nanomaterials, optical [7] and magnetic [8] effects
are the most used for biological applications.
The aim of this review is firstly to give reader a historic
prospective of nanomaterial application to biology and
medicine, secondly to try to overview the most recent
developments in this field, and finally to discuss the hard
road to commercialisation. Hybrid bionanomaterials can
also be applied to build novel electronic, optoelectronics
and memory devices (see for example [9,10]). Neverthe-
less, this will not be discussed here and will be a subject of
a separate article.
Applications
A list of some of the applications of nanomaterials to biol-
ogy or medicine is given below:
- Fluorescent biological labels [11-13]
- Drug and gene delivery [14,15]
Published: 30 April 2004
Journal of Nanobiotechnology 2004, 2:3
Received: 23 December 2003
Accepted: 30 April 2004
This article is available from: http://www.jnanobiotechnology.com/content/2/1/3
© 2004 Salata; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for 
any purpose, provided this notice is preserved along with the article's original URL.Journal of Nanobiotechnology 2004, 2 http://www.jnanobiotechnology.com/content/2/1/3
Page 2 of 6
(page number not for citation purposes)
- Bio detection of pathogens [16]
- Detection of proteins [17]
- Probing of DNA structure [18]
- Tissue engineering [19,20]
- Tumour destruction via heating (hyperthermia)[21]
- Separation and purification of biological molecules and
cells [22]
- MRI contrast enhancement [23]
- Phagokinetic studies [24]
As mentioned above, the fact that nanoparticles exist in
the same size domain as proteins makes nanomaterials
suitable for bio tagging or labelling. However, size is just
one of many characteristics of nanoparticles that itself is
rarely sufficient if one is to use nanoparticles as biological
tags. In order to interact with biological target, a biological
or molecular coating or layer acting as a bioinorganic
interface should be attached to the nanoparticle. Exam-
ples of biological coatings may include antibodies,
biopolymers like collagen [25], or monolayers of small
molecules that make the nanoparticles biocompatible
[26]. In addition, as optical detection techniques are wide
spread in biological research, nanoparticles should either
fluoresce or change their optical properties. The
approaches used in constructing nano-biomaterials are
schematically presented below (see Figure 1).
Nano-particle usually forms the core of nano-biomaterial.
It can be used as a convenient surface for molecular
assembly, and may be composed of inorganic or poly-
meric materials. It can also be in the form of nano-vesicle
surrounded by a membrane or a layer. The shape is more
often spherical but cylindrical, plate-like and other shapes
are possible. The size and size distribution might be
important in some cases, for example if penetration
through a pore structure of a cellular membrane is
required. The size and size distribution are becoming
extremely critical when quantum-sized effects are used to
control material properties. A tight control of the average
particle size and a narrow distribution of sizes allow creat-
ing very efficient fluorescent probes that emit narrow light
in a very wide range of wavelengths. This helps with creat-
ing biomarkers with many and well distinguished colours.
The core itself might have several layers and be multifunc-
tional. For example, combining magnetic and lumines-
cent layers one can both detect and manipulate the
particles.
The core particle is often protected by several monolayers
of inert material, for example silica. Organic molecules
that are adsorbed or chemisorbed on the surface of the
particle are also used for this purpose. The same layer
might act as a biocompatible material. However, more
often an additional layer of linker molecules is required to
proceed with further functionalisation. This linear linker
molecule has reactive groups at both ends. One group is
aimed at attaching the linker to the nanoparticle surface
and the other is used to bind various moieties like bio-
compatibles (dextran), antibodies, fluorophores etc.,
depending on the function required by the application.
Recent developments
Tissue engineering
Natural bone surface is quite often contains features that
are about 100 nm across. If the surface of an artificial bone
implant were left smooth, the body would try to reject it.
Because of that smooth surface is likely to cause produc-
tion of a fibrous tissue covering the surface of the implant.
This layer reduces the bone-implant contact, which may
result in loosening of the implant and further inflamma-
tion. It was demonstrated that by creating nano-sized fea-
tures on the surface of the hip or knee prosthesis one
could reduce the chances of rejection as well as to stimu-
late the production of osteoblasts. The osteoblasts are the
cells responsible for the growth of the bone matrix and are
found on the advancing surface of the developing bone.
Typical configurations utilised in nano-bio materials applied  to medical or biological problems Figure 1
Typical configurations utilised in nano-bio materials applied 
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The effect was demonstrated with polymeric, ceramic and,
more recently, metal materials. More than 90% of the
human bone cells from suspension adhered to the nanos-
tructured metal surface [27], but only 50% in the control
sample. In the end this findings would allow to design a
more durable and longer lasting hip or knee replacements
and to reduce the chances of the implant getting loose.
Titanium is a well-known bone repairing material widely
used in orthopaedics and dentistry. It has a high fracture
resistance, ductility and weight to strength ratio. Unfortu-
nately, it suffers from the lack of bioactivity, as it does not
support sell adhesion and growth well. Apatite coatings
are known to be bioactive and to bond to the bone.
Hence, several techniques were used in the past to pro-
duce an apatite coating on titanium. Those coatings suffer
from thickness non-uniformity, poor adhesion and low
mechanical strength. In addition, a stable porous structure
is required to support the nutrients transport through the
cell growth.
It was shown that using a biomimetic approach – a slow
growth of nanostructured apatite film from the simulated
body fluid – resulted in the formation of a strongly adher-
ent, uniform nanoporous layer [19]. The layer was found
to be built of 60 nm crystallites, and possess a stable nan-
oporous structure and bioactivity.
A real bone is a nanocomposite material, composed of
hydroxyapatite crystallites in the organic matrix, which is
mainly composed of collagen. Thanks to that, the bone is
mechanically tough and, at the same time, plastic, so it
can recover from a mechanical damage. The actual nano-
scale mechanism leading to this useful combination of
properties is still debated.
An artificial hybrid material was prepared from 15–18 nm
ceramic nanoparticles and poly (methyl methacrylate)
copolymer [20]. Using tribology approach, a viscoelastic
behaviour (healing) of the human teeth was demon-
strated. An investigated hybrid material, deposited as a
coating on the tooth surface, improved scratch resistance
as well as possessed a healing behaviour similar to that of
the tooth.
Cancer therapy
Photodynamic cancer therapy is based on the destruction
of the cancer cells by laser generated atomic oxygen,
which is cytotoxic. A greater quantity of a special dye that
is used to generate the atomic oxygen is taken in by the
cancer cells when compared with a healthy tissue. Hence,
only the cancer cells are destroyed then exposed to a laser
radiation. Unfortunately, the remaining dye molecules
migrate to the skin and the eyes and make the patient very
sensitive to the daylight exposure. This effect can last for
up to six weeks.
To avoid this side effect, the hydrophobic version of the
dye molecule was enclosed inside a porous nanoparticle
[28]. The dye stayed trapped inside the Ormosil nanopar-
ticle and did not spread to the other parts of the body. At
the same time, its oxygen generating ability has not been
affected and the pore size of about 1 nm freely allowed for
the oxygen to diffuse out.
Multicolour optical coding for biological assays [29]
The ever increasing research in proteomics and genomic
generates escalating number of sequence data and
requires development of high throughput screening tech-
nologies. Realistically, various array technologies that are
currently used in parallel analysis are likely to reach satu-
ration when a number of array elements exceed several
millions. A three-dimensional approach, based on optical
"bar coding" of polymer particles in solution, is limited
only by the number of unique tags one can reliably pro-
duce and detect.
Single quantum dots of compound semiconductors were
successfully used as a replacement of organic dyes in vari-
ous bio-tagging applications [7]. This idea has been taken
one step further by combining differently sized and hence
having different fluorescent colours quantum dots, and
combining them in polymeric microbeads [29]. A precise
control of quantum dot ratios has been achieved. The
selection of nanoparticles used in those experiments had
6 different colours as well as 10 intensities. It is enough to
encode over 1 million combinations. The uniformity and
reproducibility of beads was high letting for the bead
identification accuracies of 99.99%.
Manipulation of cells and biomolecules [30]
Functionalised magnetic nanoparticles have found many
applications including cell separation and probing; these
and other applications are discussed in a recent review [8].
Most of the magnetic particles studied so far are spherical,
which somewhat limits the possibilities to make these
nanoparticles multifunctional. Alternative cylindrically
shaped nanoparticles can be created by employing metal
electrodeposition into nanoporous alumina template
[30]. Depending on the properties of the template, nano-
cylinder radius can be selected in the range of 5 to 500 nm
while their length can be as big as 60 µm. By sequentially
depositing various thicknesses of different metals, the
structure and the magnetic properties of individual cylin-
ders can be tuned widely.
As surface chemistry for functionalisation of metal sur-
faces is well developed, different ligands can be selectively
attached to different segments. For example, porphyrinsJournal of Nanobiotechnology 2004, 2 http://www.jnanobiotechnology.com/content/2/1/3
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with thiol or carboxyl linkers were simultaneously
attached to the gold or nickel segments respectively. Thus,
it is possible to produce magnetic nanowires with spa-
tially segregated fluorescent parts. In addition, because of
the large aspect ratios, the residual magnetisation of these
nanowires can be high. Hence, weaker magnetic field can
be used to drive them. It has been shown that a self-assem-
bly of magnetic nanowires in suspension can be control-
led by weak external magnetic fields. This would
potentially allow controlling cell assembly in different
shapes and forms. Moreover, an external magnetic field
can be combined with a lithographically defined mag-
netic pattern ("magnetic trapping").
Protein detection [31]
Proteins are the important part of the cell's language,
machinery and structure, and understanding their func-
tionalities is extremely important for further progress in
human well being. Gold nanoparticles are widely used in
immunohistochemistry to identify protein-protein inter-
action. However, the multiple simultaneous detection
capabilities of this technique are fairly limited. Surface-
enhanced Raman scattering spectroscopy is a well-estab-
lished technique for detection and identification of single
dye molecules. By combining both methods in a single
nanoparticle probe one can drastically improve the multi-
plexing capabilities of protein probes. The group of Prof.
Mirkin has designed a sophisticated multifunctional
Table 1: Examples of Companies commercialising nanomaterials for bio- and medical applications.
Company Major area of activity Technology
Advectus Life Sciences Inc. Drug delivery Polymeric nanoparticles engineered to carry anti-
tumour drug across the blood-brain barrier
Alnis Biosciences, Inc. Bio-pharmaceutical Biodegradable polymeric nanoparticles for drug 
delivery
Argonide Membrane filtration Nanoporous ceramic materials for endotoxin 
filtration, orthopaedic and dental implants, DNA and 
protein separation
BASF Toothpaste Hydroxyapatite nanoparticles seems to improve 
dental surface
Biophan Technologies, Inc. MRI shielding Nanomagnetic/carbon composite materials to shield 
medical devices from RF fields
Capsulution NanoScience AG Pharmaceutical coatings to improve solubility of drugs Layer-by-layer poly-electrolyte coatings, 8–50 nm
Dynal Biotech Magnetic beads
Eiffel Technologies Drug delivery Reducing size of the drug particles to 50–100 nm
EnviroSystems, Inc. Surface desinfectsant Nanoemulsions
Evident Technologies Luminescent biomarkers Semiconductor quantum dots with amine or carboxyl 
groups on the surface, emission from 350 to 2500 nm
Immunicon Tarcking and separation of different cell types magnetic core surrounded by a polymeric layer 
coated with antibodies for capturing cells
KES Science and Technology, Inc. AiroCide filters Nano-TiO2 to destroy airborne pathogens
NanoBio Cortporation Pharmaceutical Antimicrobal nano-emulsions
NanoCarrier Co., Ltd Drug delivery Micellar nanoparticles for encapsulation of drugs, 
proteins, DNA
NanoPharm AG Drug delivery Polybutilcyanoacrylate nanoparticles are coated with 
drugs and then with surfactant, can go across the 
blood-brain barrier
Nanoplex Technologies, Inc Nanobarcodes for bioanalysis
Nanoprobes, Inc. Gold nanoparticles for biological markers Gold nanoparticles bio-conjugates for TEM and/or 
fluorescent microscopy
Nanoshpere, Inc. Gold biomarkers DNA barcode attached to each nanoprobe for 
identification purposes, PCR is used to amplify the 
signal; also catalytic silver deposition to amplify the 
signal using surface plasmon resonance
NanoMed Pharmaceutical, Inc. Drug delivery Nanoparticles for drug delivery
Oxonica Ltd Sunscreens Doped transparent nanoparticles to effectively 
absorb harmful UV and convert it into heat
PSiVida Ltd Tissue engineering, implants, drugs and gene delivery, 
bio-filtration
Exploiting material properties of nanostructured 
porous silicone
Smith & Nephew Acticoat bandages Nanocrystal silver is highly toxic to pathogenes
QuantumDot Corporation Luminescent biomarkers Bioconjugated semiconductor quantum dotsJournal of Nanobiotechnology 2004, 2 http://www.jnanobiotechnology.com/content/2/1/3
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probe that is built around a 13 nm gold nanoparticle. The
nanoparticles are coated with hydrophilic oligonucle-
otides containing a Raman dye at one end and terminally
capped with a small molecule recognition element (e.g.
biotin). Moreover, this molecule is catalytically active and
will be coated with silver in the solution of Ag(I) and hyd-
roquinone. After the probe is attached to a small molecule
or an antigen it is designed to detect, the substrate is
exposed to silver and hydroquinone solution. A silver-
plating is happening close to the Raman dye, which
allows for dye signature detection with a standard Raman
microscope. Apart from being able to recognise small
molecules this probe can be modified to contain antibod-
ies on the surface to recognise proteins. When tested in the
protein array format against both small molecules and
proteins, the probe has shown no cross-reactivity.
Commercial exploration
Some of the companies that are involved in the develop-
ment and commercialisation of nanomaterials in biologi-
cal and medical applications are listed below (see Table
1). The majority of the companies are small recent
spinouts of various research institutions. Although not
exhausting, this is a representative selection reflecting
current industrial trends. Most of the companies are devel-
oping pharmaceutical applications, mainly for drug deliv-
ery. Several companies exploit quantum size effects in
semiconductor nanocrystals for tagging biomolecules, or
use bio-conjugated gold nanoparticles for labelling vari-
ous cellular parts. A number of companies are applying
nano-ceramic materials to tissue engineering and
orthopaedics.
Most major and established pharmaceutical companies
have internal research programs on drug delivery that are
on formulations or dispersions containing components
down to nano sizes. Colloidal silver is widely used in anti-
microbial formulations and dressings. The high reactivity
of titania nanoparticles, either on their own or then illu-
minated with UV light, is also used for bactericidal pur-
poses in filters. Enhanced catalytic properties of surfaces
of nano-ceramics or those of noble metals like platinum
are used to destruct dangerous toxins and other hazardous
organic materials.
Future directions
As it stands now, the majority of commercial nanoparticle
applications in medicine are geared towards drug delivery.
In biosciences, nanoparticles are replacing organic dyes in
the applications that require high photo-stability as well
as high multiplexing capabilities. There are some develop-
ments in directing and remotely controlling the functions
of nano-probes, for example driving magnetic nanoparti-
cles to the tumour and then making them either to release
the drug load or just heating them in order to destroy the
surrounding tissue. The major trend in further develop-
ment of nanomaterials is to make them multifunctional
and controllable by external signals or by local environ-
ment thus essentially turning them into nano-devices.
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